Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis

Estrogen receptor (ER)-positive breast cancer patients treated with tamoxifen are known to have an elevated risk of subsequent endometrial cancer. However, it is unclear if ER-negative patients also have a higher risk of endometrial cancer. This population-based study aims to evaluate whether breast...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2015-04, Vol.150 (2), p.439-445
Hauptverfasser:	Liu, Jieqiong, Jiang, Wen, Mao, Kai, An, Yi, Su, Fengxi, Kim, Betty Y. S., Liu, Qiang, Jacobs, Lisa K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Breast cancer Breast Neoplasms - metabolism Breast Neoplasms - pathology Cancer research Cancer survivors Cancer therapies Care and treatment Endometrial cancer Endometrial Neoplasms - metabolism Epidemiology Female Health aspects Hormones Humans Incidence Medicine Medicine & Public Health Middle Aged Neoplasms, Second Primary - metabolism Oncology Receptors, Estrogen - metabolism Receptors, Progesterone - metabolism Risk Factors SEER Program Survivor Survivors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!